Subscribe

ForU Holdings, Inc. (FORU)

USD0.00 +0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address 117 South Cook Street 60010
Barrington, IL, US
CEO David Elliot Lazar
IPO 1999-12-23
ISIN US3498081054

Explore sections of this company profile

Description

ForU Holdings, Inc. functions as a holistic provider of wellness solutions, distributing a variety of nutritional items and healthcare services through its network of subsidiaries. The company is dedicated to the research and development of its own branded consumer products within the health and wellness sector, with a specific focus on functional foods and beverages. Its service offerings include a broad spectrum of in-home support, encompassing both non-medical assistance—such as light housekeeping and transportation—and medical provisions, including visits from nurses and doctors, as well as occupational, physical, and other clinical therapies. ForU Holdings also operates Wish Upon A Hero (WUAH), an online community platform designed to unite individuals in need with those able to offer aid. Further initiatives involve the development of an orally administered treatment for pediatric diarrhea, specifically aimed at the Indian market. Additionally, through self-managed business ventures, the company offers personalized health products, which feature DNA-tailored nutritional supplements, skincare solutions, and gene-modulating products for weight management. The organization, originally named Capsalus Corp., officially adopted its current identity as ForU Holdings, Inc. in July 2014. Its main offices are located in Barrington, Illinois.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2.2K
Float Shares
18.21M
Free Float %
83.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +0.00% +0.00% +0.00% +0.00% -99.80% -98.50% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-12.57
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
  • EPS growth Biotechnology: +29.7%
    +28.6% Q3'11: +81.4% (vs Q3'10)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
    -393.7% Q3'11: +14.8% (vs Q3'10)
  • Share dilution Biotechnology: -3.4%
    +119.5% Q3'11: +8.0% (vs Q3'10)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -1.66× Q3'11: 12.82× (vs Q3'10)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.00) × ERP
WACC = 0% × Ke + 100% × Kd (51.9%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-6.74M
OE per share TTM
-3.09
Owner's Yield
-2,687,980.79%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
690.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
Shares Outstanding
21.71M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Steven Grubner Chief Operating Officer 170.0K male
David Elliot Lazar Chief Executive Officer, President, Secretary, Chief Financial Officer & Chairman of the Board of Directors male
Diego E. Roca Treasurer male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits